BioReliance Director of Finance Salaries in Wilmington, DE | Comparably
BioReliance is a leading CRO providing nonclinical testing and contract manufacturing services. read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
126

BioReliance Director of Finance Salaries in Wilmington, DE

The average BioReliance Director of Finance in Wilmington, DE earns an estimated $143,514 annually. BioReliance's Director of Finance compensation is $18,501 less than the US average for a Director of Finance.

In Wilmington, DE, The Finance Department at BioReliance earns $16,379 more on average than the Admin Department.

Last updated 2 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$143,514
Average Compensation
$143,514
avg. base

Director of Finance Salaries at BioReliance

In Wilmington, DE, Directors of Finance earn $25,204 more than Accounting Managers.

Accounting Manager
$118k*
Business Analyst
$99k*
Senior Accountant
$90k*
Financial Analyst
$71k*
Accountant
$69k*
* estimated salary

Compensation at BioReliance by Department

In Wilmington, DE, The Finance Department averages $16,379 more than the Admin Department, and $15,709 less than the IT Department

IT
$98,543 Avg. total comp.
+$16k
Finance
$82,834 Avg. total comp.
Admin
$66,455 Avg. total comp.
-$16k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to BioReliance reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to BioReliance reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at BioReliance Rate Their Compensation

The majority of Directors of Finance at BioReliance believe they're compensated fairly. 50% of Directors of Finance at BioReliance say they receive annual bonuses, and the vast majority (75%) are satisfied with their benefits. See more compensation ratings at BioReliance

×
Rate your company